vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and ONESPAWORLD HOLDINGS Ltd (OSW). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($263.6M vs $242.1M, roughly 1.1× ONESPAWORLD HOLDINGS Ltd). BALCHEM CORP runs the higher net margin — 14.9% vs 5.0%, a 9.9% gap on every dollar of revenue. On growth, ONESPAWORLD HOLDINGS Ltd posted the faster year-over-year revenue change (11.5% vs 9.8%). Over the past eight quarters, ONESPAWORLD HOLDINGS Ltd's revenue compounded faster (7.1% CAGR vs 4.9%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
BCPC vs OSW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $242.1M |
| Net Profit | $39.2M | $12.1M |
| Gross Margin | 35.6% | — |
| Operating Margin | 19.8% | 6.8% |
| Net Margin | 14.9% | 5.0% |
| Revenue YoY | 9.8% | 11.5% |
| Net Profit YoY | 16.8% | -16.2% |
| EPS (diluted) | $1.21 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $242.1M | ||
| Q3 25 | $267.6M | $258.5M | ||
| Q2 25 | $255.5M | $240.7M | ||
| Q1 25 | $250.5M | $219.6M | ||
| Q4 24 | $240.0M | $217.2M | ||
| Q3 24 | $239.9M | $241.7M | ||
| Q2 24 | $234.1M | $224.9M | ||
| Q1 24 | $239.7M | $211.2M |
| Q4 25 | $39.2M | $12.1M | ||
| Q3 25 | $40.3M | $24.3M | ||
| Q2 25 | $38.3M | $19.9M | ||
| Q1 25 | $37.1M | $15.3M | ||
| Q4 24 | $33.6M | $14.4M | ||
| Q3 24 | $33.8M | $21.6M | ||
| Q2 24 | $32.1M | $15.8M | ||
| Q1 24 | $29.0M | $21.2M |
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — | ||
| Q1 24 | 34.0% | — |
| Q4 25 | 19.8% | 6.8% | ||
| Q3 25 | 20.4% | 10.2% | ||
| Q2 25 | 20.1% | 9.2% | ||
| Q1 25 | 20.4% | 7.7% | ||
| Q4 24 | 19.8% | 7.9% | ||
| Q3 24 | 20.0% | 10.3% | ||
| Q2 24 | 19.6% | 8.4% | ||
| Q1 24 | 17.4% | 8.0% |
| Q4 25 | 14.9% | 5.0% | ||
| Q3 25 | 15.1% | 9.4% | ||
| Q2 25 | 15.0% | 8.3% | ||
| Q1 25 | 14.8% | 7.0% | ||
| Q4 24 | 14.0% | 6.6% | ||
| Q3 24 | 14.1% | 8.9% | ||
| Q2 24 | 13.7% | 7.0% | ||
| Q1 24 | 12.1% | 10.0% |
| Q4 25 | $1.21 | $0.12 | ||
| Q3 25 | $1.24 | $0.23 | ||
| Q2 25 | $1.17 | $0.19 | ||
| Q1 25 | $1.13 | $0.15 | ||
| Q4 24 | $1.03 | $0.13 | ||
| Q3 24 | $1.03 | $0.20 | ||
| Q2 24 | $0.98 | $0.15 | ||
| Q1 24 | $0.89 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $16.3M |
| Total DebtLower is stronger | — | $84.0M |
| Stockholders' EquityBook value | $1.3B | $542.6M |
| Total Assets | $1.7B | $707.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $16.3M | ||
| Q3 25 | $65.1M | $29.6M | ||
| Q2 25 | $65.4M | $35.0M | ||
| Q1 25 | $49.9M | $22.6M | ||
| Q4 24 | $49.5M | $57.4M | ||
| Q3 24 | $73.7M | $48.8M | ||
| Q2 24 | $63.7M | $62.5M | ||
| Q1 24 | $60.3M | $65.4M |
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $85.2M | ||
| Q2 25 | — | $96.2M | ||
| Q1 25 | — | $97.4M | ||
| Q4 24 | — | $98.6M | ||
| Q3 24 | — | $98.7M | ||
| Q2 24 | — | $123.8M | ||
| Q1 24 | — | $138.6M |
| Q4 25 | $1.3B | $542.6M | ||
| Q3 25 | $1.3B | $552.8M | ||
| Q2 25 | $1.3B | $548.3M | ||
| Q1 25 | $1.2B | $530.6M | ||
| Q4 24 | $1.1B | $554.5M | ||
| Q3 24 | $1.2B | $540.1M | ||
| Q2 24 | $1.1B | $532.7M | ||
| Q1 24 | $1.1B | $515.5M |
| Q4 25 | $1.7B | $707.1M | ||
| Q3 25 | $1.7B | $732.6M | ||
| Q2 25 | $1.7B | $731.8M | ||
| Q1 25 | $1.6B | $708.7M | ||
| Q4 24 | $1.6B | $746.4M | ||
| Q3 24 | $1.6B | $734.0M | ||
| Q2 24 | $1.6B | $756.8M | ||
| Q1 24 | $1.6B | $763.6M |
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $20.0M |
| Free Cash FlowOCF − Capex | — | $14.9M |
| FCF MarginFCF / Revenue | — | 6.2% |
| Capex IntensityCapex / Revenue | — | 2.1% |
| Cash ConversionOCF / Net Profit | 1.72× | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | $68.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $20.0M | ||
| Q3 25 | $65.6M | $33.2M | ||
| Q2 25 | $47.3M | $20.3M | ||
| Q1 25 | $36.5M | $10.1M | ||
| Q4 24 | $52.3M | $16.6M | ||
| Q3 24 | $51.3M | $28.6M | ||
| Q2 24 | $45.0M | $18.7M | ||
| Q1 24 | $33.4M | $15.0M |
| Q4 25 | — | $14.9M | ||
| Q3 25 | — | $27.6M | ||
| Q2 25 | — | $17.6M | ||
| Q1 25 | — | $8.4M | ||
| Q4 24 | — | $13.2M | ||
| Q3 24 | — | $27.5M | ||
| Q2 24 | — | $17.6M | ||
| Q1 24 | — | $13.7M |
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | — | 7.3% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | 7.8% | ||
| Q1 24 | — | 6.5% |
| Q4 25 | — | 2.1% | ||
| Q3 25 | — | 2.2% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 1.72× | 1.65× | ||
| Q3 25 | 1.63× | 1.36× | ||
| Q2 25 | 1.23× | 1.02× | ||
| Q1 25 | 0.98× | 0.66× | ||
| Q4 24 | 1.56× | 1.15× | ||
| Q3 24 | 1.52× | 1.33× | ||
| Q2 24 | 1.40× | 1.19× | ||
| Q1 24 | 1.15× | 0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
OSW
| Services | $197.3M | 82% |
| Products | $44.8M | 18% |
